You might have seen Cialis® — the erectile dysfunction (ED) drug — available in doses ranging from 2.5 mg to 20 mg. Surely, ...

Indian drugmaker Hikma has agreed in principle to a $150 million settlement to resolve lawsuits claiming that it contributed to the opioid crisis in the US, which could allow it to put the ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC: 2100 ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.67% to £19.20 Tuesday, on what proved to be an all-around rough trading ...

Hikma Pharmaceuticals will acquire parts of Danish firm Xellia Pharmaceuticals, a drug company specialising in injectable ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma ... We closed the Xellia acquisition in September and expect a revenue contribution of around $20 million this year, in line with previously ...

Hikma Pharmaceuticals PLC HIK shares advanced 1.67% to £18.31 Friday, on what proved to be an all-around dismal trading ...

If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...